1[1]Manninen V,Elo Mo,Frick MH,et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA, 1988,260(5): 641-651.
2[2]Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Sinvastatin Survival Study (4S). Lancet,1994,344:1383-1389.
3[3]Clifford L, Basil M,Christopher T, et al. Declining serum total cholesterol levels among US adults. JAMA, 1993,269: 3002-3023.
4[4]Lee Goldman MD. MPH,Milton C,Weinstein PHD,et al. Costeffectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease. JAMA, 1991,265: 1145-1151.
5[5]Tusuf S,Wittes J,Friedman L. Overview of results of randomized clinical trials in heart disease. Ⅱ. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA,1988,260:2259-2263.
6[6]Frank E,Winkleby MA,Fortmann SP,et al. Improved cholesterol-related knowledge and behavior and plasma cholesterol levels in adults during the 1980s. JAMA, 1992, 268:1566-1572.
7[7]Christopher T,James L,Margaret D,et al. Prevalence of High Blood Cholesterol Among US Adults. An update Bassed on Guidelines From the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA, 1993,269: 3009-3014.
8[8]Fulk E. Why do plaques rupture? Circulation, 1992, 86 (6 Suppl): Ⅲ30-42.
